WOODCLIFF LAKE, N.J., July 5 (UPI) -- U.S. drug maker Barr said Thursday its subsidiary Duramed has received approval in Canada to market extend-cycle oral contraceptive Seasonale.
CHIACGO, June 14 (UPI) -- Periodontal diseases are a threat to women of all ages due to hormonal fluctuations that occur at various stages of their lives, found two U.S. studies.
COLLEGEVILLE, Pa., May 23 (UPI) -- Wyeth said late Tuesday the U.S. Food and Drug Administration approved Lybrel, an oral contraceptive that stops a woman's menstrual cycle.
WAYNE, N.J., May 7 (UPI) -- Bayer HealthCare and Intendis said Monday they will co-promote the contraceptive Yaz on the U.S. market as a duo pill for birth control/acne.
WAYNE, N.J., Jan. 29 (UPI) -- Berlex said Monday the U.S. Food and Drug Administration approved its oral contraceptive Yaz for treating acne.
WAYNE, N.J., Oct. 5 (UPI) -- Berlex said Thursday the Food and Drug Administration approved its oral contraceptive, Yaz, for treating premenstrual dysphoric disorder.
CORONA, Calif., Sept. 7 (UPI) -- Watson said Thursday the Food and Drug Administration approved its generic formulation of Duramed's oral contraceptive Seasonale.
WAYNE, N.J., March 17 (UPI) -- Berlex said Friday the Food and Drug Administration approved its oral contraceptive Yaz, with rollout set for April.
ROCKAWAY, N.J., Feb. 20 (UPI) -- Warner Chilcott said late Friday its oral contraceptive Loestrin 24 FE has been approved for market.
BERLIN, Dec. 9 (UPI) -- Schering AG said Friday that review of its contraceptive YAZ has been extended until early 2006.
